Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan

被引：0
|
作者：
Mitsukuni Suenaga
Nobuyuki Mizunuma
Daigo Shouji
Eiji Shinozaki
Satoshi Matsusaka
Keisho Chin
Masatoshi Oya
Toshiharu Yamaguchi
Tetsuichiro Muto
Kiyohiko Hatake
机构：
[1] Japanese Foundation for Cancer Research,Department of Medical Oncology, Cancer Institute Hospital
[2] Japanese Foundation for Cancer Research,Division of Gastroenterological Surgery, Cancer Institute Hospital
来源：
Journal of Gastroenterology | 2008年 / 43卷
关键词：
irinotecan; 5-fluorouracil; colorectal cancer; IFL;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：842 / 848
页数：6
相关论文
共 50 条
  • [21] Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer
    Jeffrey A. Meyerhardt
    Jeffrey W. Clark
    Jeffrey G. Supko
    Joseph P. Eder
    Shuji Ogino
    Clinton F. Stewart
    Ferdinando D’Amato
    Janet Dancey
    Peter C. Enzinger
    Andrew X. Zhu
    David P. Ryan
    Craig C. Earle
    Robert J. Mayer
    Ann Michelini
    Kate Kinsella
    Charles S. Fuchs
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 661 - 670
  • [22] Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer
    Meyerhardt, Jeffrey A.
    Clark, Jeffrey W.
    Supko, Jeffrey G.
    Eder, Joseph P.
    Ogino, Shuji
    Stewart, Clinton F.
    D'Amato, Ferdinando
    Dancey, Janet
    Enzinger, Peter C.
    Zhu, Andrew X.
    Ryan, David P.
    Earle, Craig C.
    Mayer, Robert J.
    Michelini, Ann
    Kinsella, Kate
    Fuchs, Charles S.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (05) : 661 - 670
  • [23] Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer
    Berlin, Jordan
    Posey, James
    Tchekmedyian, Simon
    Hu, Eddie
    Chan, David
    Malik, Imtiaz
    Yang, Liqiang
    Amado, Rafael G.
    Hecht, J. Randolph
    CLINICAL COLORECTAL CANCER, 2007, 6 (06) : 427 - 432
  • [24] Health-Related Quality of Life Impact of Bevacizumab When Combined with Irinotecan, 5-Fluorouracil, and Leucovorin or 5-Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
    Kabbinavar, Fairooz F.
    Wallace, Joel F.
    Holmgren, Eric
    Yi, Jing
    Cella, David
    Yost, Kathleen J.
    Hurwitz, Herbert I.
    ONCOLOGIST, 2008, 13 (09): : 1021 - 1029
  • [25] Phase II study of irinotecan, leucovorin, 5-fluorouracil and tegafur/uracil for metastatic colorectal cancer
    Kono, T
    Ebisawa, Y
    Tomita, I
    Chisato, N
    Kamiya, K
    Asama, T
    Ayabe, T
    Ashida, T
    Kohgo, Y
    Kasai, S
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (02) : 224 - 227
  • [26] OUR EXPERIENCE WITH IRINOTECAN AND BOLUS FLUOROURACIL/LEUCOVORIN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
    Davidov, Deyan
    JOURNAL OF IMAB, 2009, 15 (01): : 49 - 52
  • [27] Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: A new survival standard
    Saltz, LB
    Douillard, JY
    Pirotta, N
    Alakl, M
    Gruia, G
    Awad, L
    Elfring, GL
    Locker, PK
    Miller, LL
    ONCOLOGIST, 2001, 6 (01): : 81 - 91
  • [28] Double modulation of 5-fluorouracil by methotrexate and high-dose L-leucovorin in advanced colorectal cancer
    Romero, AO
    Perez, JE
    Cuevas, MA
    Lacava, JA
    Sabatini, CL
    Dominguez, ME
    Rodriguez, R
    Barbieri, MR
    Ortiz, EH
    Salvadori, MA
    Acuna, LAR
    Acuna, JMR
    Langhi, MJ
    Amato, S
    Machiavelli, MR
    Leone, BA
    Vallejo, CT
    Lorusso, V
    DeLena, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (01): : 94 - 98
  • [29] Multicenter phase II study of irinotecan plus weekly bolus 5-FU and high dose l-leucovorin for patients with metastatic colorectal cancer (OGSG 0201).
    Ishida, H
    Mishima, H
    Iwamoto, S
    Morimoto, T
    Kato, T
    Tsujinaka, T
    Furukawa, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 298S - 298S
  • [30] IRINOTECAN, FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Davidov, Deyan
    JOURNAL OF IMAB, 2008, 14 (01): : 48 - 50
12345